Check-Cap (NASDAQ:CHEK) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Check-Cap (NASDAQ:CHEK) in a report issued on Saturday morning. The firm issued a sell rating on the medical research company’s stock.

Check-Cap Trading Down 5.9 %

Shares of Check-Cap stock opened at $0.74 on Friday. Check-Cap has a twelve month low of $0.56 and a twelve month high of $3.04. The stock has a market capitalization of $4.35 million, a price-to-earnings ratio of -0.25 and a beta of 0.20. The business’s 50 day simple moving average is $0.76 and its 200-day simple moving average is $0.96.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.